Futuristic Solu (534063)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Recent bottom-line recovery: latest quarter net profit of ₹1 Cr and reported profit growth of 1000%.
• Book value is positive at ₹13.67 per share; equity cushion is not negative.
• Piotroski F-Score of 5/9 suggests the company passes more than half of basic financial-health checks.

Concerns

• Extreme valuation: P/E 91.56, P/B 7.20, zero dividend, and price at the 52-week high of ₹98.45.
• Poor capital productivity: ROE only 5.66% and ROCE -0.39%, while sales growth is 0.00%.
• The 1000% profit growth is from a negligible base and not backed by sales growth; latest quarter sales are just ₹1 Cr.
• Transparency gap: promoter holding N/A and FairStock Score insufficient; financials are too small to trust.

AI Analysis

As a Graham-style investor, I don't need brilliant businesses; I need numbers I can trust. This name gives me neither. Futuristic Solu has a market cap of ₹103 Cr and trades at ₹98.45, but the business earned barely enough to support a P/E of 91.56. Book value is only ₹13.67, so I am paying 7.2 times book for a company earning just 5.66% on equity. The core return on capital employed is -0.39%, which tells me operations are not genuinely profitable; the latest quarterly net profit of ₹1 Cr may look good only because the base is tiny. Sales growth is 0.00%, and quarterly sales are just ₹1 Cr. A 1000% profit growth figure with a PEG of 0.09 looks exciting, but Buffett would call that a base-effect illusion, not a franchise. Zero dividend. Promoter holding is not disclosed, and FairStock cannot even score it. I have no margin of safety. If I pay ₹98 for ₹13.67 of book value and less than ₹1.10 of annual earnings, I need years of flawless execution - and there is no evidence of that. The stock has already gone from ₹33.25 to its 52-week high of ₹98.45. The market may be pricing a miracle; I cannot underwrite a miracle. A Piotroski score of 5/9 is moderate, not a green light. Maybe this is an early turnaround, but the sales line isn't moving. This is speculation dressed up as growth. I will wait for either a much lower price or a long record of real revenue and return on capital.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer